相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。S1P(1) receptor expression regulates emergence of NKT cells in peripheral tissues
Maria L. Allende et al.
FASEB JOURNAL (2008)
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma
Qing Liu et al.
BLOOD (2008)
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
Thierry Walzer et al.
NATURE IMMUNOLOGY (2007)
Donor bone marrow type II (Non-Vα14Jα18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-γ and IL-4
Ji Hyung Kim et al.
JOURNAL OF IMMUNOLOGY (2007)
Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy
Yosuke Kurashima et al.
JOURNAL OF IMMUNOLOGY (2007)
Erythrocytes store and release sphingosine 1-phosphate in blood
Petra Haenel et al.
FASEB JOURNAL (2007)
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice
Jerzy-Roch Nofer et al.
CIRCULATION (2007)
Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants
Adam C. Yopp et al.
CLINICAL TRANSPLANTATION (2006)
Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function
Marco Idzko et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer
Shinichiro Motohashi et al.
CLINICAL CANCER RESEARCH (2006)
IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-γ-producing neutrophils
Su Jin Hwang et al.
JOURNAL OF IMMUNOLOGY (2006)
The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology
Henrik von Wenckstern et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2006)
NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor β, and by clonally deleting antigen-specific T cells
HJ Kim et al.
IMMUNOLOGY (2006)
Efficient synthesis of the immunosuppressive agent FTY720
SH Kim et al.
SYNTHESIS-STUTTGART (2006)
FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors
K Chiba
PHARMACOLOGY & THERAPEUTICS (2005)
Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-γ
JH Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients
SR Schwab et al.
SCIENCE (2005)
Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer.: Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer
R Albert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
S1P1-selective in vivo-active agonists from high-throughput screening:: Off-the-shelf chemical probes of receptor interactions, signaling, and fate
EJ Jo et al.
CHEMISTRY & BIOLOGY (2005)
Imatinib mesylate blocks a non-smad TGF-beta pathway and reduces renal fibrogenesis in vivo
SN Wang et al.
FASEB JOURNAL (2005)
NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production
HY Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Practical synthesis of KRN7000 from phytosphingosine
S Kim et al.
SYNTHESIS-STUTTGART (2004)
CD1d-dependent activation of NKT cells aggravates atherosclerosis
E Tupin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
FTY720-Enhanced T cell homing is dependent on CCR2, CCR5, CCR7, and CXCR4: Evidence for distinct chemokine compartments
AC Yopp et al.
JOURNAL OF IMMUNOLOGY (2004)
Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity
O Akbari et al.
NATURE MEDICINE (2003)
Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells
JH Xie et al.
JOURNAL OF IMMUNOLOGY (2003)
FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes
SM Honig et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines
G Gonzalez-Aseguinolaza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Arthritis critically dependent on innate immune system players
H Ji et al.
IMMUNITY (2002)
Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
S Sharif et al.
NATURE MEDICINE (2001)
Requirement for natural killer T (NKT) cells in the induction of allograft tolerance
K Seino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosime-1-phosphate receptors
RL Malek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression
V Brinkmann et al.
TRANSPLANTATION PROCEEDINGS (2001)
Evidence that FTY720 induces T cell apoptosis in vivo
Y Nagahara et al.
IMMUNOPHARMACOLOGY (2000)
A novel transcription factor, T-bet, directs Th1 lineage commitment
SJ Szabo et al.
CELL (2000)
Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats
M Matsuura et al.
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY (2000)
FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
V Brinkmann et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
分享论文
